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and antioxidative capacity in the VAT of young female rats 
can be implicated in the development of adiposity, but do 
not affect inhibitory phosphorylation of IRS-1.
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Introduction
Dramatic increase in fructose consumption, mainly through 
sweetened beverages, arises many health concerns, as it is 
suspected to contribute to the development of metabolic 
syndrome (MetS), a major risk factor for type 2 diabetes 
and cardiovascular diseases. Namely, fructose overcon-
sumption has been associated with different pathologies 
recognized in the syndrome including weight gain, visceral 
adiposity, impaired glucose tolerance, insulin resistance, 
hypertriglyceridemia, and dyslipidemia in both humans 
[1–3] and animals [4–7]. Between 1980 and 2013, the prev-
alence of overweight and obesity rose by 47.1 % for chil-
dren [8].
Visceral adiposity is a hallmark of MetS [9], and adi-
pose tissue is no longer considered as a passive energy 
storage, but as an active endocrine organ that secrets vari-
ous hormones and cytokines, collectively referred as adi-
pokines [10]. There are increasing data showing that obe-
sity is accompanied by a chronic low-grade inflammatory 
state [10, 11], especially considering increased levels of 
pro-inflammatory cytokines (IL-1β, TNFα) in adipose 
tissue and circulation of obese individuals, which seem 
to decrease after weight loss [12–15]. Also, IL-1β gene 
expression in visceral adipose tissue (VAT) is positively 
correlated with waist circumference [16]. Importantly, 
IL-1β and TNFα produced by adipose tissue are implicated 
Abstract 
Purpose The consumption of refined, fructose-enriched 
food continuously increases and has been linked to devel-
opment of obesity, especially in young population. Low-
grade inflammation and increased oxidative stress have 
been implicated in the pathogenesis of obesity-related dis-
orders including type 2 diabetes. In this study, we exam-
ined alterations in inflammation and antioxidative defense 
system in the visceral adipose tissue (VAT) of fructose-fed 
young female rats, and related them to changes in adiposity 
and insulin sensitivity.
Methods We examined the effects of 9-week fructose-
enriched diet applied immediately after weaning on nuclear 
factor κB (NF-κB) intracellular distribution, and on the 
expression of pro-inflammatory cytokines (IL-1β and 
TNFα) and key antioxidative enzymes in the VAT of female 
rats. Insulin signaling in the VAT was evaluated at the level 
of insulin receptor substrate-1 (IRS-1) protein and its inhib-
itory phosphorylation on Ser307.
Results Fructose-fed rats had increased VAT mass along 
with increased NF-κB nuclear accumulation and elevated 
IL-1β, but not TNFα expression. The protein levels of 
antioxidative defense enzymes, mitochondrial manganese 
superoxide dismutase 2, and glutathione peroxidase, were 
reduced, while the protein content of IRS-1 and its inhibi-
tory phosphorylation were not altered by fructose diet.
Conclusions The results suggest that fructose overcon-
sumption-related alterations in pro-inflammatory markers 
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in promoting the obesity-related insulin resistance and 
type 2 diabetes [17, 18]. Long-term treatment with IL-1β 
induces insulin resistance in adipocytes [19], and several 
proposed mechanisms include reduction in IRS-expression 
as demonstrated both in 3T3-L1 and in human adipocytes 
[20], stimulation of IRS-1 Ser307 phosphorylation [21, 22], 
which inhibits kinase activity of insulin receptor [23], and 
induction of TNFα expression [22]. TNFα induces inhibi-
tory phosphorylation of IRS-1on Ser307 residue [24, 25]. 
In addition, obese mice genetically lacking TNFα are pro-
tected from obesity-induced deficiency in insulin signaling 
[26].
Nuclear factor-κB (NF-κB) is an inducible transcription 
factor with the essential role in transcriptional activation of 
pro-inflammatory genes including TNFα and IL-1β [27–
29]. In most cells, it consists of NF-κB1 (p50)/RelA (p65) 
heterodimer and resides latent in the cytoplasm inactivated 
by inhibitory IκB proteins that mask the nuclear localiza-
tion signal of the dimer members. The activation of NF-κB, 
as a cellular response to pro-inflammatory cytokines, free 
radicals, stress, bacterial, and viral agents, involves phos-
phorylation and degradation of IκB protein, which leads to 
NF-κB translocation to the nucleus and activation of gene 
expression [30].
There are findings indicating that oxidative stress is 
implicated in adiposity, insulin resistance, and MetS [31, 
32]. Reactive oxygen species (ROS) are involved in the 
activation of NF-κB by mediating the release of inhibi-
tory subunit IκB from NF-κB [33]. During homeostasis, 
ROS are generated as products of oxidative metabolism 
and during stress their production increases dramatically. 
The redox balance in the cell is maintained by antioxida-
tive enzymes such as cytoplasmic copper–zinc superoxide 
dismutase 1 (SOD1), mitochondrial manganese superoxide 
dismutase 2 (SOD2), glutathione peroxidase (GPx), glu-
tathione reductase (GRed), and non-enzymatic compounds 
(reduced glutathione, vitamins A, E, C, beta-carotene, etc.). 
Oxidative stress emerges when production of ROS exceeds 
the capacity of antioxidative defense system, and oxidative 
stress markers are increased in patients with MetS [34]. In 
addition, systemic oxidative stress is correlated with body 
mass index (BMI) [35, 36], while antioxidative capacity 
decreases with the accumulation of VAT [37, 38].
Recently, fructose-enriched diet has been associated 
with VAT endocrine dysfunction including the up-regula-
tion of inflammatory markers [39, 40]. Also, fructose was 
reported to produce a pro-oxidative effect and to alter the 
expression of antioxidative enzymes in the rat [41].
The consumption of refined food rich in fructose contin-
uously increases in children and commonly replaces nutri-
tious foods. Randomized clinical trials and meta-analyses 
have linked fructose overconsumption to the development 
of childhood obesity [42]. In addition, gender differences 
in the metabolome of obese adolescents are suggested to 
begin in childhood [43]. In spite of the obvious need for 
gender- and age-specific information, studies examining 
the deleterious effects of fructose overconsumption on met-
abolic disturbances were mainly undertaken in adult male 
subjects.
We have previously reported that young, fructose-
fed female rats developed increased adiposity that was 
accompanied with elevated expression of 11β hydroxys-
teroid dehydrogenase type 1 (HSD1) and reduced gluco-
corticoid receptor hormone-binding capacity and affin-
ity in the VAT [44]. It is tempting to speculate that these 
changes stem from inflammation and disruption of anti-
oxidative system that have been described in the states of 
increased adiposity and obesity. In this study, we tested 
the hypothesis that long-term fructose consumption 
induces inflammation and alterations in the antioxidative 
defense system in the VAT of young female rats, contrib-
uting to the development of obesity and impairment of 
insulin signaling. To test this hypothesis, we analyzed the 
level and intracellular distribution of NF-κB, the expres-
sion of pro-inflammatory cytokines (IL-1β and TNFα), 
and antioxidative enzymes (SOD1, SOD2, GPx and 
GRed), as well as insulin signaling at the level of IRS-1 
protein and its phosphorylation on Ser307 in the VAT of 
female rats subjected to 9-week fructose-enriched diet 
immediately after weaning.
Materials and methods
Material
Fructose was purchased from Apipek (Becˇej, Serbia). 
Anti-SOD1 (ab13489), anti-SOD2 (ab13533), anti-GRed 
(ab16801), and anti-GPx (ab22604) antibodies were 
obtained from Abcam (Cambridge, UK), anti-NF-κB/p65 
(sc-372), and anti-IRS-1 (sc-8038) were products of Santa 
Cruz Biotechnology, and anti-phospho-IRS-1 (Ser307) (07-
247) was from Millipore-Upstate, and anti-β-actin anti-
body (AC 15) was from Sigma Chemicals (St. Louis, MO, 
USA). Polyvinylidene difluoride (PVDF) membrane and 
enhanced chemifluorescent (ECF) Western blotting reagent 
pack, containing anti-mouse (IgG + IgM) and anti-rabbit 
IgG alkaline phosphatase-linked whole antibodies, and 
ECF substrate were obtained from Amersham Pharma-
cia Biotech, UK. High capacity cDNA reverse transcrip-
tion kit, RNase inhibitor, TaqMan® Universal PCR Master 
Mix with AmpErase UNG, and TaqMan® Gene Expression 
Assay primer-probe mix for: IL-1β (Rn00580432_m1), 
TNFα (Rn01525859_g1), and hypoxanthine phosphoribo-
syltransferase 1 (HPRT1) (Rn01527840_m1) were all prod-
ucts of Applied Biosystems. TRIzol®Reagent (AmBion), 
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RNase-free DNase I (Ferments), and RNase–DNase-free 
water (Eppendorf) were also used.
Animals and treatment
Female Wistar rats (21 days old, 50.83 ± 3.78 g), bred in 
our laboratory, were randomly divided into two dietary-
based experimental groups: a control group fed with com-
mercial standard chow and drinking water and a fructose 
group fed with the same chow and 10 % (w/v) fructose 
solution instead of drinking water. Both experimental 
groups had ad libitum access to food and drinking fluid 
during 9 weeks. Animals (9 per group) were housed three 
per cage and kept under standard conditions, 22 °C with a 
12-h light/dark cycle. All animal procedures were in com-
pliance with Directive 2010/63/EU on the protection of 
animals used for experimental and other scientific purposes 
and were approved by the Ethical Committee for the Use of 
Laboratory Animals of the Institute for Biological Research 
“Siniša Stanković,” University of Belgrade.
Plasma parameters
Animals were killed by rapid decapitation after overnight 
fasting during which both experimental groups were pro-
vided only with drinking water. Blood glucose levels were 
determined by MultiCare strips (Biochemical Systems 
International, Italia). For plasma preparation, the trunk 
blood from each experimental animal was collected in the 
separate EDTA-coated tube and centrifuged at 3000 rpm 
for 10 min. Plasma was stored at −20 °C until use. The 
plasma insulin level was determined by the RIA method, 
using rat insulin standards. Assay sensitivity was 0.6 mIU/l, 
and an intra-assay coefficient of variation was 5.24 %. The 
plasma osmolarity, as a measure of body’s electrolyte–
water balance, was calculated from the measured Na+, 
urea, and glucose concentrations as follows: 2(Na+) + glu-
cose + urea (mmol/L).
Preparation of cytosol, nucleosol, and mitochondrial 
fraction
Visceral adipose tissue was excised, washed with saline, 
dried, and stored in liquid nitrogen until use. After thaw-
ing, the tissue was homogenized in 1 vol (w/v) of ice-cold 
homogenization buffer (20 mM Tris–HCl, pH 7.4, con-
taining 10 % glycerol, 50 mM NaCl, 2 mM dithiothreitol, 
1 mM EDTA-Na2, 1 mM EGTA-Na2, 20 mM Na2MoO4, 
protease and phosphatase inhibitors). Homogenates were 
centrifuged 10 min at 2000g, 4 °C, and the supernatants 
(S1) were used to obtain cytosols and mitochondrial frac-
tions, while nucleosols were obtained from the pellets (P1). 
Supernatants S1 were centrifuged 30 min at 20,000g, 4 °C 
to obtain crude mitochondrial pellets, and supernatants 
were finally centrifuged for 1 h at 105,000g, 4 °C to obtain 
cytosols. The crude mitochondrial pellets were washed 
three times in homogenization buffer. Pellets were then 
incubated for 1.5 h on ice in lysis buffer (50 mM Tris–HCl, 
pH 7.4, containing 5 % glycerol, 1 mM EDTA, 5 mM DTT, 
protease inhibitors and 0.05 % Triton X-100) with frequent 
vortexing, yielding mitochondrial extracts [45], which were 
used for SOD2 detection. To obtain nucleosols, pellets P1 
were washed in 0.5 ml homogenization buffer (10 min at 
2000 g, 4 °C), resuspended in 1 vol (w/v) of NUN buffer 
(25 mM HEPES, pH 7.6, 1 M Urea, 300 mM NaCl, 1 % 
Nonidet P-40, 2 mM dithiothreitol, 20 mM Na2MoO4, pro-
tease and phosphatase inhibitors) and incubated for 1 h on 
ice with frequent vortexing. After incubation, samples were 
centrifuged (10 min at 8000g, 4 °C) and the supernatants 
were used as the nucleosols.
SDS–polyacrylamide gel electrophoresis and Western 
blotting
Samples were mixed 1:1 with 2× Laemmli’s buffer and 
boiled for 5 min. Proteins (50 μg) were separated by elec-
trophoresis through SDS–polyacrylamide gels (7.5 or 
12 %). After electrophoresis, proteins were transferred onto 
PVDF membrane using a blot system (Transblot, BioRad). 
Unbound sites on the membranes were blocked with 1 % 
nonfat dry milk for 1.5 h. To detect NF-κB (p65 subunit), 
SOD1, SOD2, GR, GPx, IRS-1, and pIRS-1 (Ser307) mem-
branes were incubated with appropriate primary antibod-
ies, followed by alkaline phosphatase-conjugated second-
ary antibodies (1:20,000). For correction of protein load, 
membranes were stripped using 0.2 M NaOH, blocked and 
probed for β-actin with AC 15 antibody (1:10,000) and 
respective secondary antibody. The purity of cytoplasmic, 
nuclear, and mitochondrial fractions was verified using spe-
cific antibodies against cytoplasmic IκB-α, nuclear c-Jun, 
and mitochondrial mHsp70 proteins. Immunopositive 
bands were visualized by the ECF reaction, and their rela-
tive optical densities were measured by the STORM scan-
ner (Amersham, UK). Quantitative analysis was done by 
ImageQuant software.
RNA extraction and reverse transcription
Total RNA was extracted from thawed VAT (100–200 mg) 
using TRIzol®Reagent following the manufacturer’s pro-
tocol. RNA was dissolved in 30 µl of RNase–DNase-
free water, and RNase inhibitor was added. Concentra-
tion and purity were tested spectrophotometrically (OD 
260/280 > 1.8 was considered satisfactory). RNA integrity 
was confirmed by 1 % agarose gel electrophoresis. Prior 
to cDNA synthesis, DNA contamination was removed by 
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DNAse I treatment (Fermentas), according to the manufac-
turer’s instructions. cDNA was synthesized from 2 µg of 
RNA. The reverse transcription was performed in a 20-μl 
reactions with MultiScribe™ Reverse Transcriptase in the 
presence of Random Primers using High Capacity cDNA 
Reverse Transcription kit. Reactions were carried out under 
RNase-free conditions at 25 °C for 10 min followed by 
37 °C for 2 h and final denaturation at 85 °C for 5 min. The 
cDNA was stored at −80 °C until further use.
Real‑time PCR
The expression of IL-1β and TNFα was analyzed by 
TaqMan qPCR using AB Prism 7,000 Sequence Detec-
tor System. All reactions were performed in 25-µl vol-
ume in triplicates and mean Ct value for each triplicate 
was used for further analysis. Reaction mix consisted of 
1 × TaqMan® Universal PCR Master Mix, with AmpErase 
UNG, 1 × TaqMan® Gene Expression Assay and cDNA 
template (20 ng of RNA converted to cDNA). Thermal 
cycling conditions were: 2-min incubation at 50 °C for 
UNG activation, 10 min at 95 °C followed by 40 cycles 
of 95 °C for 15 s and 60 °C for 60 s. No template control 
was included for each target gene to detect possible reagent 
contamination. Relative quantification of gene expression 
was performed using comparative 2−ΔΔCt method. HPRT1 
was used as previously validated reference gene [46].
Statistical analysis
Student’s t test (two-tailed) was used to compare differ-
ences between experimental groups. A probability level 
<0.05 was considered to be statistically significant.
Results
On daily basis, animals on fructose diet consumed signifi-
cantly smaller amount of food (P < 0.01), but more liquid 
and energy (P < 0.05) in comparison with those on stand-
ard diet. The consumption of 10 % fructose solution did 
not disturb the electrolyte–water balance, as plasma osmo-
larity values were similar for all animals. Body mass of 
fructose-fed rats was not significantly altered compared to 
the controls, whereas VAT mass and its ratio to body mass 
(P < 0.05) were increased, indicating increased visceral 
adiposity in these animals. In addition, fructose-fed ani-
mals had significantly reduced fasting blood glucose levels 
(P < 0.05), while the plasma insulin levels were not altered 
(Table 1).
To investigate the effects of fructose overconsumption 
on the NF-κB protein level and its intracellular redistribu-
tion in VAT of female rats, cytosols and nucleosols were 
analyzed using Western blot procedure. The NF-κB protein 
level was significantly decreased in the cytosols (by 30 %, 
P < 0.01), and simultaneously, elevated in the nucleosols 
(by 60 %, P < 0.05) of VAT from fructose-fed female rats 
(Fig. 1).
When the expression of NF-κB-regulated pro-inflam-
matory genes in the VAT was followed using qPCR, a sig-
nificant (P < 0.05) elevation of IL-1β mRNA level was 
observed (by 40 %), while the level of TNFα expression did 
not differ between fructose-fed and control animals (Fig. 2).
Table 1  Energy intake, body and visceral adipose tissue mass, and 
plasma parameters
Values are expressed as mean ± SEM
Caloric intake is expressed per day per animal
VAT Visceral adipose tissue
* P < 0.05, ** P < 0.01
Control Fructose
Energy from chow (kJ) 191.51 ± 10.96 138.49 ± 2.46**
Energy from fructose (kJ) – 96.65 ± 11.70*
Energy intake (kJ) 191.51 ± 10.96 236.06 ± 10.07*
Body mass (g) 259.00 ± 9.55 271.23 ± 8.48
Plasma osmolarity (mmol/l) 317.4 ± 2.08 323.2 ± 11.13
Mass of VAT (g) 3.20 ± 0.44 5.06 ± 0.82*
VAT-to-body ratio (×1000) 12.43 ± 1.74 18.29 ± 2.51*
Glucose (mM) 5.38 ± 0.65 4.58 ± 0.84*
Insulin (mIU/l) 6.60 ± 2.50 8.87 ± 3.97
Fig. 1  Effects of fructose overconsumption on NF-κB intracellular 
redistribution in the visceral adipose tissue of female rats. Groups: 
control (C), fructose-fed (FRU). NF-κB protein level was meas-
ured by Western blot in the cytosols and nucleosols of the visceral 
adipose tissue. Relative integrated optical density of the immunore-
active bands corresponding to NF-κB were assessed by ImageQuant 
software, normalized to β-actin (cytosols) or lamin B (nucleo-
sols), and expressed in arbitrary units (AU). The values represent 
the mean ± SEM (n = 9). Statistical significance of the difference 
between experimental groups (Student’s t test): *P < 0.05; **P < 0.01
155Eur J Nutr (2017) 56:151–160 
1 3
Possible effects of long-term high-fructose diet on the anti-
oxidative defense system were evaluated. Analysis of relative 
protein levels of antioxidative enzymes revealed that fructose-
enriched diet significantly (P < 0.05) decreased GPx and SOD2 
protein level by 30 and 40 %, respectively, and had no effect on 
the SOD1 and GRed in the VAT from female rats (Fig. 3).
The influence of fructose-enriched diet on insulin signal-
ing in VAT was examined. The total IRS-1 protein abun-
dance and the level of IRS-1 phosphorylated on Ser307 
(evaluated by the pIRS-1 (Ser307)/total IRS-1 ratio) were 
not altered by fructose feeding (Fig. 4).
Discussion
In this study, we observed pro-inflammatory state as dem-
onstrated by increased NF-κB nuclear accumulation and 
elevated IL-1β gene expression together with reduced 
protein levels of antioxidative defense enzymes SOD2 
and GPx in the VAT of female rats subjected to fructose-
enriched diet immediately after weaning. In addition, while 
both the absolute and relative VAT masses were increased 
in fructose-fed rats, the signs of insulin resistance were not 
observed.
Chronic, low-grade inflammation has been implicated in 
the pathogenesis and progression of obesity-related meta-
bolic disorders including type 2 diabetes [11, 17, 18], and 
dietary fructose was found to cause inflammation in animal 
models [39, 40]. However, data on fructose-related inflam-
mation in adipose tissue of young females are missing.
We observed decreased protein level of NF-κB tran-
scriptionally active subunit p65 in the cytoplasm and its 
significant elevation in the nuclei, indicating activation 
of this pro-inflammatory transcription factor in the VAT 
of fructose-fed female rats. In parallel, the expression 
of IL-1β, a cytokine positively regulated by NF-κB, was 
enhanced, while the expression of TNFα was not signifi-
cantly increased. These results provide evidence for fruc-
tose diet-related inflammation. Similarly, fructose-related 
activation of cardiac NF-κB was previously reported [47], 
but in contrast to our results obtained in females, it was 
not observed in the VAT of young male rats [48]. Several 
researchers reported elevated IL-1β and TNFα in the liver 
[49] and plasma [50–52] after fructose feeding. In the study 
of Hsieh [53], dietary fructose was shown to elicit TNFα 
concentrations in the adipose tissue of male rats. Taken 
together, these results suggest that the effects of fructose 
feeding differ between tissues and genders. Our observa-
tion is in line with findings of increased IL-1β expression 
in adipose tissue of obese humans [14] and of different 
models of rodent obesity, both diet-induced and genetic 
[54]. Though IL-1β was shown to induce TNFα expres-
sion in adipocytes [22], and elevated expression of TNFα 
Fig. 2  mRNA level of anti-inflammatory cytokines in the visceral 
adipose tissue of female rats. The level of IL-1β and TNFα mRNAs 
relative to HPRT mRNA in control (C) and fructose-fed (FRU) ani-
mals was determined by TaqMan real-time PCR and expressed 
as fold change of control. The values represent the mean ± SEM 
(n = 9). All measurements were done in triplicates. The values rep-
resent the mean ± SEM (n = 9). Statistical significance of the differ-
ence between experimental groups (Student’s t test): *P < 0.05
Fig. 3  Protein level of antioxidative enzymes in the visceral adipose 
tissue of female rats subjected to fructose-rich diet immediately after 
weaning. Groups: control (C), fructose-fed (FRU). Relative integrated 
optical density of the immunoreactive bands corresponding to SOD1, 
SOD2, GPx or GRed obtained after Western blotting were assessed 
by ImageQuant software, normalized to β-actin and expressed in 
arbitrary units (AU). The values represent the mean ± SEM (n = 9). 
Statistical significance of the difference between experimental groups 
(Student’s t test): *P < 0.05
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was described in adipose tissue of obese humans [55] and 
mice [56], it was not observed herein. Nevertheless, unal-
tered TNFα expression in the VAT of fructose-fed animals 
is in accordance with unaltered plasma FFA concentration 
and unaltered peroxisome proliferator-activated recep-
tor γ (PPARγ) expression in VAT that we have previously 
reported in the same experimental animals [44]. Namely, 
TNFα increases circulating FFA levels in vivo and in vitro 
presumably by down-regulation of proteins involved in 
FFA trapping in adipocytes, resulting in reduced re-esteri-
fication of FFA, as reviewed in [57]. It also suppresses the 
expression of PPARγ, which regulates the expression of 
genes that promote fatty acid storage [58, 59].
Glucocorticoid hormones inhibit NF-κB-mediated 
expression of pro-inflammatory genes by direct interaction 
of glucocorticoid receptor with p65 in the nucleus [60]. We 
propose that NF-κB-regulated IL-1β expression is facili-
tated by HSD1-driven homologous down-regulation of glu-
cocorticoid receptor, since our previously published results 
obtained in the same experimental animals showed elevated 
HSD1 protein level and intracellular corticosterone, as well 
as a consequent down-regulation of glucocorticoid receptor 
expression and function in the VAT [44]. On the other hand, 
since IL-1β can induce HSD1 expression and activity in the 
adipose tissue [61], these events might contribute to further 
propagation of inflammation, closing a vicious cycle.
The activation of NF-κB has been described as an essen-
tial step in promoting diet- and obesity-induced insulin 
resistance [62] and increased expression and release of 
IL-1β is viewed as an important manifestation of adipose 
tissue inflammation and a key factor in the propagation 
of obesity-related inflammation to insulin resistance [54]. 
Although IL-1β could affect insulin sensitivity via TNFα-
dependent and TNFα-independent pathways [22] in the 
VAT, in our study the total IRS-1 protein abundance and the 
pIRS-1 (Ser307)/total IRS-1 ratio were not altered by fruc-
tose feeding, indicating preserved insulin sensitivity in the 
adipose tissue of fructose-fed female rats.
Systemic insulin resistance was not observed in this 
animal model, as we previously confirmed by unaltered 
HOMA index and intraperitoneal glucose tolerance test 
[63]. Interestingly, plasma glucose was not increased, but 
even decreased, pointing to elevated insulin sensitivity, 
although the plasma insulin was unaltered. In the study of 
Teff [64], consumption of fructose-sweetened beverages 
resulted in lower 24-h circulating glucose in women, while 
in several animal studies long-term fructose consumption 
was shown to increase plasma glucose and insulin concen-
tration, as well as to impair glucose tolerance and insulin 
sensitivity [51, 65]. However, in young male rats exposed to 
fructose diet immediately after weaning, such effects were 
not observed [63]. The existence of plausible protective 
mechanism specific for young females remains to be eluci-
dated, although in young and middle-aged women, higher 
consumption of sugar-sweetened beverages was reported to 
be associated with an increased risk of development of type 
2 diabetes [66]. Additionally, scarce literature data on young 
population indicate that elevated inflammatory markers, 
insulin resistance, and decreased antioxidants, all accom-
pany high fructose intake in children with fatty liver [67]. 
However, enhanced insulin sensitivity has been proposed 
as a risk factor for development of type 2 diabetes based 
on the emerging evidence that enhanced insulin action in 
adipose tissue may precede insulin resistance [68, 69]. 
Therefore, our results might reflect the situation before the 
onset of insulin resistance. Indeed, longitudinal studies that 
would check for this assumption are needed. Clarifying the 
time course of events in development of insulin resistance 
that would enable recognition of early symptoms would be 
especially beneficial for children and adolescents who are 
daily exposed to fructose overconsumption. We suspect 
that prolonged diet and/or increased fructose concentration 
would lead to insulin resistance. It is likely that VAT inflam-
mation is particularly important for the onset and develop-
ment of insulin resistance, since hepatic and skeletal muscle 
inflammation in either lean or obese mice was not detected 
[56]. Considering the NF-κB activation and elevated IL‑1β 
expression in the VAT without insulin resistance in fructose-
fed animals together with the fact that IL-1β can induce 
insulin resistance in adipocytes [19], our work supports the 
stand that VAT inflammation represents one of the earliest 
metabolic perturbations upon fructose overconsumption.
Fig. 4  Effects of fructose overconsumption on IRS-1 protein level 
and phosphorylation in the visceral adipose tissue of female rats. 
Groups: control (C), fructose-fed (FRU). The level of total IRS-1 and 
inhibitory Ser307 phosphorylation of IRS-1 protein was measured by 
Western blot in the cytosols of the visceral adipose tissue. Bar graphs 
of total IRS-1 protein content (normalized to β-actin) and the ratio of 
pIRS-1(Ser307)/IRS-1 are shown. The values are expressed as percent-
age of control animals and represent the mean ± SEM (n = 9)
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The absence of insulin resistance in the VAT further 
confirms our previously published data that VAT accumula-
tion in young fructose-fed female rats is due to inhibited 
lipolysis [44]. Namely, in these animals, lipolysis is inhib-
ited both by preserved insulin signaling, which is the major 
physiological suppressor of lipolysis, and by the absence 
of lipolytic actions of glucocorticoid receptor [44]. As dis-
cussed above, IL-1β has the ability to induce HSD1 expres-
sion and activity in adipose tissue [61], which, in our study, 
led to down-regulation of glucocorticoid signaling. These 
findings confirm the stand that VAT inflammation can con-
tribute to the development of adiposity and obesity.
How can fructose diet induce NF-κB activation is not 
clear. NF-κB translocation to the nucleus can occur as a 
result of free fatty acids (FFA)-induced activation of toll-
like receptors in adipocytes [70], though, as reported in 
our previous study [44], circulating levels of FFA were not 
elevated in fructose-fed female rats. Whether FFA gener-
ated from VLDL during lipid uptake by adipocytes could 
activate NF-κB pathway has not been elucidated.
Elevated intracellular ROS could also contribute to the 
NF-κB activation. One of the harmful effects of nutri-
ent excess in obesity, when glucose and/or FFA oxidation 
are elevated, is cellular overproduction of ROS. Here, it is 
likely that fructose-fed animals had reduced antioxidative 
capacity as we observed decreased protein level of SOD2 
and GPx in the adipose tissue of these animals compared to 
controls. The protein level of other two enzymes involved 
in the antioxidative protection, SOD1 and GRed, was not 
altered.
Fructose consumption is implicated in promoting oxida-
tive stress, as plasma insulin and H2O2 are increased in rats 
fed high fructose [41]. A large body of literature data dem-
onstrate deleterious effects of fructose diet on antioxidative 
defense system, i.e., fructose overconsumption has been 
shown to reduce activity and/or expression of antioxidative 
enzymes in adipose and other organs such as liver and mus-
cle of adult female [71, 72] and male [51, 65, 73] rats. Of 
note, in human studies erythrocyte SOD1 and GPx activi-
ties are negatively associated with BMI and morbidly obese 
subjects have significantly lower erythrocyte SOD1 and 
GPx than those with normal BMI [36]. The contribution of 
oxidative stress in fructose-related metabolic disturbances 
is further documented by the observation that antioxidants 
reduce ROS production, elevate activity of antioxidative 
enzymes, and alleviate insulin resistance in fructose-fed 
animals [50, 52, 74].
The presence of oxidative stress is commonly accom-
panied by increased levels of pro-inflammatory cytokines 
including IL-1β and TNFα along with disturbed insulin 
signaling [49–52]. There is a complex relationship between 
inflammation and oxidative stress in obesity and related 
disorders that seems to be revolving in the vicious cycle; 
hence, the time course has not been established yet. On 
the one hand, pro-inflammatory cytokines appear to be 
potent stimulators of oxygen and nitrogen reactive species 
production in adipose tissue, and on the other hand, ROS 
mediate the release of inhibitory subunit IκB from NF-κB 
[33], thus activating NF-κB and allowing its translocation 
to the nucleus. Based on the observation that antioxidative 
defense was diminished in fructose-fed animals, we assume 
that ROS might be elevated in these animals, contributing 
to activation of NF-κB.
Because of the small amount of VAT, the parameters 
of oxidative stress such as the total thiol content, reduced/
oxidized glutathione ratio, and the markers of lipid peroxi-
dation were not analyzed. A number of studies have dem-
onstrated decreased expression or activity of antioxidative 
enzymes after fructose consumption and a concomitant 
presence of oxidative stress [49, 51, 65]. The oxidative 
environment evoked by fructose overconsumption might be 
an explanation for decreased glucocorticoid receptor’s hor-
mone-binding capacity and affinity observed in our previ-
ous study [44]. Glucocorticoid receptor is a redox-sensitive 
transcription factor, the binding capacity of which is main-
tained by preserving sulfhydryl groups in its ligand-binding 
domain in reduced state [75]. Besides, oxidative stress was 
shown to impair the receptor’s interaction with Hsp90, the 
chaperone responsible for the maturation of the receptor’s 
high-affinity hormone-binding conformation [76].
Cavarape et al. [73] reported that the expression of anti-
oxidative enzymes was markedly reduced in the liver and 
heart, while only slightly in the adipose tissue of fructose-
fed rats. Glucose and TG were not increased in their study 
indicating the importance of adipose tissue in the onset of 
metabolic disturbances. Reduced antioxidative defense in 
the VAT of female rats that we report herein is in agree-
ment with this concept, as are our unpublished data demon-
strating unchanged expression and activity of antioxidative 
enzymes and the absence of oxidative stress in the liver of 
fructose-fed female rats.
In summary, results of this study show that fructose-
enriched diet applied immediately after weaning can induce 
inflammation and derange antioxidative defense system in 
the VAT of female rats. We propose that these alterations 
could be involved in the development of adiposity, at least 
in part, by modulating glucocorticoid signaling. Whether 
the observed fructose-related perturbations would eventu-
ally lead to insulin resistance in young females remains to 
be elucidated.
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